These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1136 related articles for article (PubMed ID: 25016220)
1. Thyrotropin increases hepatic triglyceride content through upregulation of SREBP-1c activity. Yan F; Wang Q; Lu M; Chen W; Song Y; Jing F; Guan Y; Wang L; Lin Y; Bo T; Zhang J; Wang T; Xin W; Yu C; Guan Q; Zhou X; Gao L; Xu C; Zhao J J Hepatol; 2014 Dec; 61(6):1358-64. PubMed ID: 25016220 [TBL] [Abstract][Full Text] [Related]
2. Peroxisome proliferator-activated receptor α activation induces hepatic steatosis, suggesting an adverse effect. Yan F; Wang Q; Xu C; Cao M; Zhou X; Wang T; Yu C; Jing F; Chen W; Gao L; Zhao J PLoS One; 2014; 9(6):e99245. PubMed ID: 24926685 [TBL] [Abstract][Full Text] [Related]
3. Honokiol activates the LKB1-AMPK signaling pathway and attenuates the lipid accumulation in hepatocytes. Seo MS; Kim JH; Kim HJ; Chang KC; Park SW Toxicol Appl Pharmacol; 2015 Apr; 284(2):113-24. PubMed ID: 25737164 [TBL] [Abstract][Full Text] [Related]
4. [Effects of soothing liver and invigorating spleen recipes on SREBP-1c, SCD-1 mRNA and proteins expression in hepatocytes of NAFLD rats]. Xu YJ; Yang QH; Han L; Zhang YP; Liu YZ; Jin L; Yan HZ Zhong Yao Cai; 2014 Jan; 37(1):80-6. PubMed ID: 25090711 [TBL] [Abstract][Full Text] [Related]
6. Berberine attenuates nonalcoholic hepatic steatosis through the AMPK-SREBP-1c-SCD1 pathway. Zhu X; Bian H; Wang L; Sun X; Xu X; Yan H; Xia M; Chang X; Lu Y; Li Y; Xia P; Li X; Gao X Free Radic Biol Med; 2019 Sep; 141():192-204. PubMed ID: 31226399 [TBL] [Abstract][Full Text] [Related]
7. Deoxypodophyllotoxin in Anthriscus sylvestris alleviates fat accumulation in the liver via AMP-activated protein kinase, impeding SREBP-1c signal. Kim KY; Park KI; Lee SG; Baek SY; Lee EH; Kim SC; Kim SH; Park SG; Yu SN; Oh TW; Kim JH; Kim KJ; Ahn SC; Kim YW Chem Biol Interact; 2018 Oct; 294():151-157. PubMed ID: 30148990 [TBL] [Abstract][Full Text] [Related]
8. SREBP-1c impairs ULK1 sulfhydration-mediated autophagic flux to promote hepatic steatosis in high-fat-diet-fed mice. Nguyen TTP; Kim DY; Lee YG; Lee YS; Truong XT; Lee JH; Song DK; Kwon TK; Park SH; Jung CH; Moon C; Osborne TF; Im SS; Jeon TI Mol Cell; 2021 Sep; 81(18):3820-3832.e7. PubMed ID: 34233158 [TBL] [Abstract][Full Text] [Related]
9. The Combination of Blueberry Juice and Probiotics Ameliorate Non-Alcoholic Steatohepatitis (NASH) by Affecting SREBP-1c/PNPLA-3 Pathway via PPAR-α. Ren T; Zhu J; Zhu L; Cheng M Nutrients; 2017 Feb; 9(3):. PubMed ID: 28264426 [TBL] [Abstract][Full Text] [Related]
10. Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice. Hsu WH; Chen TH; Lee BH; Hsu YW; Pan TM Food Chem Toxicol; 2014 Feb; 64():94-103. PubMed ID: 24275089 [TBL] [Abstract][Full Text] [Related]
11. The PKA-SREBP1c Pathway Plays a Key Role in the Protective Effects of Lactobacillus johnsonii JNU3402 Against Diet-Induced Fatty Liver in Mice. Hong E; Kang H; Yang G; Oh S; Kim E Mol Nutr Food Res; 2023 Oct; 67(20):e2200496. PubMed ID: 37650271 [TBL] [Abstract][Full Text] [Related]
12. Effects of the new thiazolidine derivative LPSF/GQ-02 on hepatic lipid metabolism pathways in non-alcoholic fatty liver disease (NAFLD). Araújo S; Soares E Silva A; Gomes F; Ribeiro E; Oliveira W; Oliveira A; Lima I; Lima MDC; Pitta I; Peixoto C Eur J Pharmacol; 2016 Oct; 788():306-314. PubMed ID: 27349145 [TBL] [Abstract][Full Text] [Related]
13. GPR119: a promising target for nonalcoholic fatty liver disease. Yang JW; Kim HS; Im JH; Kim JW; Jun DW; Lim SC; Lee K; Choi JM; Kim SK; Kang KW FASEB J; 2016 Jan; 30(1):324-35. PubMed ID: 26399788 [TBL] [Abstract][Full Text] [Related]
14. Smurf1 aggravates non-alcoholic fatty liver disease by stabilizing SREBP-1c in an E3 activity-independent manner. Zhang X; Zhan Y; Lin W; Zhao F; Guo C; Chen Y; Du M; Li D; Zhang L; An W; Wang HR; Xie P FASEB J; 2020 Jun; 34(6):7631-7643. PubMed ID: 32301540 [TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNA lncARSR promotes hepatic lipogenesis via Akt/SREBP-1c pathway and contributes to the pathogenesis of nonalcoholic steatohepatitis. Zhang M; Chi X; Qu N; Wang C Biochem Biophys Res Commun; 2018 Apr; 499(1):66-70. PubMed ID: 29555473 [TBL] [Abstract][Full Text] [Related]
16. Retinol binding protein 4 stimulates hepatic sterol regulatory element-binding protein 1 and increases lipogenesis through the peroxisome proliferator-activated receptor-γ coactivator 1β-dependent pathway. Xia M; Liu Y; Guo H; Wang D; Wang Y; Ling W Hepatology; 2013 Aug; 58(2):564-75. PubMed ID: 23300015 [TBL] [Abstract][Full Text] [Related]
17. Thyroid hormone-responsive SPOT 14 homolog promotes hepatic lipogenesis, and its expression is regulated by liver X receptor α through a sterol regulatory element-binding protein 1c-dependent mechanism in mice. Wu J; Wang C; Li S; Li S; Wang W; Li J; Chi Y; Yang H; Kong X; Zhou Y; Dong C; Wang F; Xu G; Yang J; Gustafsson JÅ; Guan Y Hepatology; 2013 Aug; 58(2):617-28. PubMed ID: 23348573 [TBL] [Abstract][Full Text] [Related]
18. (S)YS-51, a novel isoquinoline alkaloid, attenuates obesity-associated non-alcoholic fatty liver disease in mice by suppressing lipogenesis, inflammation and coagulation. Park EJ; Kim YM; Kim HJ; Jang SY; Oh MH; Lee DH; Chang KC Eur J Pharmacol; 2016 Oct; 788():200-209. PubMed ID: 27343380 [TBL] [Abstract][Full Text] [Related]
19. Vitamin D attenuates high fat diet-induced hepatic steatosis in rats by modulating lipid metabolism. Yin Y; Yu Z; Xia M; Luo X; Lu X; Ling W Eur J Clin Invest; 2012 Nov; 42(11):1189-96. PubMed ID: 22958216 [TBL] [Abstract][Full Text] [Related]